BPC-157 vs Glutathione
Research Verdict
Glutathione is the stronger research reference for the stated comparison criteria. Glutathione: endogenous tripeptide antioxidant with extensive human pharmacological, supplementation, and clinical data across dermatology, hepatology, and toxicology.
Quick Answers
Which is better, BPC-157 or Glutathione?
Glutathione is the stronger research reference for the stated comparison criteria. Glutathione: endogenous tripeptide antioxidant with extensive human pharmacological, supplementation, and clinical data across dermatology, hepatology, and toxicology.
What is the key difference between BPC-157 and Glutathione?
Glutathione is the primary endogenous antioxidant with well-characterized redox biology and oral/IV/topical human safety data; BPC-157 is a synthetic gastric peptide targeting tissue repair - antioxidant defense vs. tissue regeneration.
Evidence Comparison
Glutathione: endogenous tripeptide antioxidant with extensive human pharmacological, supplementation, and clinical data across dermatology, hepatology, and toxicology. BPC-157: 70+ rodent studies, single research group, no human data. Glutathione has categorically stronger human evidence.
Evidence Context Favoring BPC-157
Tissue repair, tendon healing, or GI protection preclinical research where BPC-157's specific rodent data is relevant.
Evidence Context Favoring Glutathione
Any application requiring human evidence, antioxidant research, or established safety profile - glutathione has extensive human data.
Side-by-Side Snapshot
| Evidence grade | BPC-157: Level B Glutathione: Level C |
|---|---|
| Research status | BPC-157: Phase 2 Glutathione: Phase 2 |
| Primary category | BPC-157: Healing & Recovery Glutathione: Anti-Aging & Longevity |
| Cited studies | BPC-157: 10 Glutathione: 3 |